DRREDDY vs RELIANCE: Stock Comparison

Dr Reddys Laboratories Ltd vs Reliance Industries LtdUpdated 18 August 2026, 11:27 AM ISTNSE & company filings

Reliance Industries Ltd is the larger company by market capitalisation. Dr Reddys Laboratories Ltd shows a higher ROE, a higher dividend yield and lower leverage, while Reliance Industries Ltd shows a lower P/E and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

DRREDDY leads 6; RELIANCE leads 7 of 13

Not a rating
These companies operate in different sectors (Healthcare vs Oil Gas & Consumable Fuels). Valuation and leverage norms differ across sectors, so cross-sector ratio comparisons can mislead — compare each against its own sector peers too.

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

DRREDDYRELIANCE

Valuation lens

What price are you paying?

Market CapContext only
DRREDDY
₹99,159 Cr
RELIANCE
₹17.92 L Cr
P/E RatioRELIANCE has the lower reading
DRREDDY
30.87x
RELIANCE
23.88x
P/B RatioRELIANCE has the lower reading
DRREDDY
2.63x
RELIANCE
1.97x
EPSRELIANCE has the higher reading
DRREDDY
₹39.72
RELIANCE
₹55.54
Book ValueContext only
DRREDDY
₹460.31
RELIANCE
₹668.05
Dividend YieldDRREDDY has the higher reading
DRREDDY
0.67%
RELIANCE
0.46%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
RELIANCE is the larger company
₹17.92 L Cr vs ₹99,159 Cr
P/E Ratio
RELIANCE has a lower P/E
23.88x vs 30.87x
P/B Ratio
RELIANCE has a lower P/B
1.97x vs 2.63x
EPS
RELIANCE has higher earnings per share
₹55.54 vs ₹39.72
Dividend Yield
DRREDDY has a higher dividend yield
0.67% vs 0.46%
Revenue Growth (TTM YoY)
RELIANCE has faster revenue growth
12.5% vs -11.6%
EPS Growth (TTM YoY)
RELIANCE has faster EPS growth
-12.6% vs -86.2%
Qtr Sales Growth
RELIANCE has stronger quarterly sales growth
12.5% vs -11.5%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricDRREDDYRELIANCE
SectorHealthcareOil Gas & Consumable Fuels
IndustryPharmaceuticalsRefineries & Marketing

Price

MetricDRREDDYRELIANCE
Live Price₹1,187.2₹1,323.2
Day Change-0.4%0.55%
Volume4.28 L34.3 L
52-Week High₹1,414.9₹1,611.8
52-Week Low₹1,101₹1,249.8
Distance from 52W High-16.09%-17.91%

Valuation

MetricDRREDDYRELIANCE
Market Cap₹99,159 Cr₹17.92 L Cr
P/E Ratio30.87x23.88x
P/B Ratio2.63x1.97x
EPS₹39.72₹55.54
Book Value₹460.31₹668.05
Dividend Yield0.67%0.46%

Growth

MetricDRREDDYRELIANCE
Revenue Growth (TTM YoY)-11.6%12.5%
EPS Growth (TTM YoY)-86.2%-12.6%
Qtr Sales Growth-11.5%12.5%
Qtr Profit Growth-86.1%-12.6%

Profitability & Leverage

MetricDRREDDYRELIANCE
ROE11.2%8.91%
ROCE13%10.3%
Net Margin12.76%7.64%
Operating Margin19.2%17%
Debt to Equity0.2x0.45x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricDRREDDYRELIANCE
Promoter Holding26.64% 0.01 pp50.48% 0.48 pp
FII Holding32.07% 1.01 pp17.2% 1.47 pp
DII Holding31.74% 1.02 pp21.19% 0.64 pp
Public Holding9.35% 0.02 pp11.04% 0.35 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Dr Reddys Laboratories Ltd and Reliance Industries Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.